Hannah Joseph Hospital
Close ·
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures at the close · TTM
- ROCE
- 17.80%
- Debt to Equity
- 0.28
- EPS (TTM)
- —
- Book Value
- ₹42.90
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 2.61
- ROE
- 15.00%
- Dividend Yield
- 1.81%
- EBITDA
- ₹25.70 Cr
- 52W High
- ₹128.80
- 52W Low
- ₹55.99
Key Insights
Strengths
3- Company has reduced debt.
- Company has delivered good profit growth of 46.3% CAGR over last 5 years
- Debtor days have improved from 29.0 to 16.1 days.
Weaknesses
1- Company has a low return on equity of 13.7% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 6 | 10 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 0 | 2 | 8 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 58.12
- Neutral
- MACD (12,26,9)
- 0.42
- Bullish
- SMA (50)
- 108.65
- Bullish
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +20.64% |
|---|---|
| 3Y | +18.71% |
| 1Y | +17.95% |
Net profit
| 5Y | Turned to profit |
|---|---|
| 3Y | +122.40% |
| 1Y | +57.14% |
Operating cash flow
| 5Y | +24.57% |
|---|---|
| 3Y | 0.00% |
| 1Y | +10.53% |
Operating margin· change in pp
| 5Y | +7.73 pp |
|---|---|
| 3Y | −3.74 pp |
| 1Y | +0.25 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2021 | ₹36.00 Cr |
|---|---|
| Mar 2023 | ₹55.00 Cr |
| Mar 2024 | ₹63.00 Cr |
| Mar 2025 | ₹78.00 Cr |
| Mar 2026 | ₹92.00 Cr |
Net profit by year
| Mar 2021 | −₹2.00 Cr |
|---|---|
| Mar 2023 | ₹1.00 Cr |
| Mar 2024 | ₹4.00 Cr |
| Mar 2025 | ₹7.00 Cr |
| Mar 2026 | ₹11.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 37 | 43 | 50 |
| Expenses | 28 | 31 | 36 |
| Operating Profit | 9 | 12 | 13 |
| OPM % | 25% | 28% | 27% |
| Other Income | 0 | 0 | 0 |
| Interest | 2 | 2 | 1 |
| Depreciation | 4 | 3 | 3 |
| PBT | 4 | 7 | 9 |
| Tax % | 26% | 27% | 32% |
| Net Profit | 3 | 5 | 6 |
| EPS (₹) | 1.87 | 3.07 | 2.67 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 36 | 55 | 63 | 78 | 92 |
| Expenses | 28 | 38 | 45 | 57 | 67 |
| Operating Profit | 7 | 17 | 18 | 21 | 25 |
| OPM % | 21% | 30% | 29% | 27% | 27% |
| Other Income | 2 | 0 | 0 | 0 | 1 |
| Interest | 5 | 6 | 5 | 3 | 3 |
| Depreciation | 7 | 9 | 8 | 7 | 7 |
| PBT | −2 | 1 | 5 | 10 | 16 |
| Tax % | 0% | 0% | 24% | 30% | 30% |
| Net Profit | −2 | 1 | 4 | 7 | 11 |
| EPS (₹) | −1.54 | 0.62 | 2.44 | 4.32 | 4.93 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 2 | 16 | 17 | 17 | 23 |
| Reserves | 23 | 18 | 29 | 35 | 75 |
| Borrowings | 57 | 43 | 32 | 37 | 27 |
| Other Liabilities | 13 | 15 | 13 | 8 | 9 |
| Total Liabilities | 94 | 92 | 90 | 97 | 133 |
| Fixed Assets | 86 | 71 | 65 | 69 | 73 |
| CWIP | 0 | 0 | 0 | 1 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 21 | 25 | 27 | 55 |
| Total Assets | 94 | 92 | 90 | 97 | 133 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 7 | 21 | 8 | 19 | 21 |
| Investing | −8 | −5 | −4 | −14 | −49 |
| Financing | 2 | −10 | −3 | −3 | 25 |
| Net Cash Flow | 1 | 5 | 2 | 3 | −3 |
| Free Cash Flow | −1 | 17 | 6 | 7 | 6 |
| CFO/EBITDA | 105 | 126 | 44 | 109 | 101 |
Ratios
| Particulars | Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 22 | 37 | 46 | 25 | 16 |
| Inventory Days | 54 | 73 | 54 | 47 | 51 |
| Days Payable | 176 | 136 | 102 | 90 | 97 |
| Cash Conversion Cycle | −101 | −25 | −2 | −18 | −30 |
| Working Capital Days | −81 | −83 | −11 | −28 | −17 |
| ROCE % | — | — | 13% | 17% | 18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Hannah Joseph Hospital insights
50 extracted metrics across FY21–FY26.
Documents
- Concall · Jun 2026PPT
- General announcements 28 Oct 2026
- General announcements 26 Oct 2026
- General announcements 6 Oct 2026
Frequently Asked Questions about Hannah Joseph Hospital
What does Hannah Joseph Hospital Ltd do?
Where is Hannah Joseph Hospital Ltd (HANNAH) listed?
Which sector does Hannah Joseph Hospital Ltd belong to?
What is the 52-week high and low of Hannah Joseph Hospital Ltd?
Does Hannah Joseph Hospital Ltd pay dividends?
What is the Return on Equity (ROE) of Hannah Joseph Hospital Ltd?
Company Information
Incorporated in 2011, Hannah Joseph Hospital Limited is a healthcare provider offering exceptional medical services across various specialties.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544687.md for Hannah Joseph Hospital Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.